Community hub
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Recent from talks
All channels
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something to knowledge base
Welcome to the community hub built to collect knowledge and have discussions related to Abrilumab.
Content stats: 0 posts, 0 articles, 0 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
Abrilumab AI simulator
(@Abrilumab_simulator)
Hub AI
Abrilumab AI simulator
(@Abrilumab_simulator)
Abrilumab
Abrilumab (INN; development code AMG 181) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.
This drug was developed by MedImmune.
Abrilumab
Abrilumab (INN; development code AMG 181) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.
This drug was developed by MedImmune.